Hematologic Malignancies

Neuro-Oncology

Questions discussed in this category

How do different inflammatory markers like CRP and ferritin contribute differently, if at all, to the monitoring of CART neurotoxicity?

1 Answer available

What are the best radiation therapy options for a young adult with 3 brain metastases from myeloid sarcoma that hasn’t responded well to intrathecal therapy?

Specifically, what dose and treatment volumes are recommended?

1 Answer available

How do you time CSF analysis for suspected CNS lymphoma in patients who are on steroids?

1 Answer available

For patients with primary CNS lymphoma and less than a CR to chemotherapy, in what situation would you consider partial or focal radiation?

1 Answer available

How would you manage a primary dural low-grade lymphoma?

Would you consider observation following surgical resection with negative margins? Would you recommend WBRT and/or ISRT? What would be your preferred ...

2 Answers available

How do you decide on the modality of consolidative treatment after a CR in primary CNS lymphoma patients treated with a high-dose methotrexate regimen?

How do you decide between WBRT, maintenance chemotherapy, or stem cell transplantation?

2 Answers available

Papers discussed in this category

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-09-01

Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).

Leukemia & lymphoma, 2017-04

Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-05-10

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.

Neurooncol Adv, 2023 Jan-Dec

Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma.

Radiation oncology (London, England), 2013 Oct 22

Clinicopathologic features and responses to radiotherapy of myeloid sarcoma.

Hematologic Malignancies

Neuro-Oncology

Questions discussed in this category

Papers discussed in this category

Related Topics in Hematologic Malignancies